title: Subacute myelo-optic neuropathy (SMON) induced by antituberculous treatment in uraemia.
authors.affiliation: Department of Neurology, General Hospital, USSL 34, Chiari, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Donati
authors.forename: C
authors.initials: C
authors.lastname: Bargnani
authors.forename: R
authors.initials: R
authors.lastname: Besana
authors.forename: P
authors.initials: P
authors.lastname: Locatelli
authors.forename: L
authors.initials: L
authors.lastname: Faggi
authors.forename: S
authors.initials: S
authors.lastname: De Marinis
mesh_terms: D000328:Adult; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects*; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications*; D006801:Humans; D008297:Male; D009188:Myelitis, Transverse / Q000139:chemically induced*; D009460:Neurologic Examination; D009902:Optic Neuritis / Q000139:chemically induced*; D010292:Paresthesia / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014511:Uremia / Q000150:complications*; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D004977:Ethambutol